LT - 1-[2-(2,4-Dimetilfenilsulfanil)fenil]piperazinas kaip junginys su suderintu serotonino grįžtamuoju sugėrimu, 5-HT3 IR 5-HT1A aktyvumu, skirtas skausmo arba depresijos liekamųjų simptomų, susijusių su miegu ir pažinimu, gydymui
EN - 1-[2-(2,4-DIMETHYLPHENYLSULFANYL)PHENYL]PIPERAZINE AS A COMPOUND WITH COMBINED SEROTONIN REUPTAKE, 5-HT3 AND 5-HT1A ACTIVITY FOR THE TREATMENT OF PAIN OR RESIDUAL SYMPTOMS IN DEPRESSION RELATING TO SLEEP AND COGNITION
Legal status
Patent lapsed (non-payment of fees)
Bibliographic data
Indications of the International Patent Classification (IPC)
| (51) |
INT.CL. |
A61K 31/495 |
(2006.01) |
|
|
C07D 295/08 |
(2006.01) |
|
|
A61P 25/04 |
(2006.01) |
|
|
A61P 25/24 |
(2006.01) |
|
|
A61P 25/26 |
(2006.01) |
|
|
A61P 25/28 |
(2006.01) |
|
|
A61P 25/22 |
(2006.01) |
European patent
| (11) |
Number of the document |
2142193 |
| (13) |
Kind of document |
T |
| (96) |
European patent application number |
08715617.0 |
|
Date of filing the European patent application |
2008-03-14 |
| (97) |
Date of publication of the European application |
2010-01-13 |
| (45) |
Date of publication and mention of the grant of the patent |
2011-01-19
|
| (46) |
Date of publication of the claims translation |
2011-05-25
|
PCT application
| (86) |
Number |
PCT/DK2008/050063 |
|
Date |
2008-03-14 |
PCT application publication
| (87) |
Number |
WO 2008/113359 |
|
Date |
2008-09-25 |
Priority applications
| (30) |
Number |
Date |
Country code |
|
200700427 |
2007-03-20
|
DK |
|
PCT/DK2007/0500 |
2007-06-15
|
WO |
Inventors
| (72) |
MOORE, Nicholas, US
STENSBÖL, Tine, Bryan, DK
|
Grantee
| (73) |
H. Lundbeck A/S,
Ottiliavej 9, 2500 Valby-Copenhagen,
DK
|
Attorney or representative
| (74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
Title
| (54) |
1-[2-(2,4-Dimetilfenilsulfanil)fenil]piperazinas kaip junginys su suderintu serotonino grįžtamuoju sugėrimu, 5-HT3 IR 5-HT1A aktyvumu, skirtas skausmo arba depresijos liekamųjų simptomų, susijusių su miegu ir pažinimu, gydymui |
| |
1-[2-(2,4-DIMETHYLPHENYLSULFANYL)PHENYL]PIPERAZINE AS A COMPOUND WITH COMBINED SEROTONIN REUPTAKE, 5-HT3 AND 5-HT1A ACTIVITY FOR THE TREATMENT OF PAIN OR RESIDUAL SYMPTOMS IN DEPRESSION RELATING TO SLEEP AND COGNITION |
Last renewal fee
|
Payment date |
Validity (years) |
Amount |
|
2023-03-02 |
16 |
347.00
EUR
|
Legal status
|
Patent lapsed (non-payment of fees)
|
|
|
Invalidation date |
2024-03-14 |
